News
On Oct. 14, the Centers for Medicare & Medicaid Services shared important reminders about Quality Payment Program (QPP) deadlines, including those for exception applications and Merit-based Incentive Payment System (...
Read More
The acquisition of the national home sleep testing provider aims to bring EEG-enabled testing to primary care, telehealth, and specialty providers starting in 2027.
Read More
Drawing on data from the NIH's All of Us research program, researchers reveal a more comprehensive picture of the everyday challenges facing people with narcolepsy.
Read More
Preliminary findings from a phase 4 study highlight significant improvements in nighttime awakenings and vasomotor symptoms among menopausal women using the non-hormonal treatment fezolinetant.
Read More
Project Sleep CEO Julie Flygare shares her firsthand experience with Orzeyful and the questions she hopes clinicians will consider as the treatment enters clinical practice.
Read More
Data from 11 countries reveals consistent drops in deep sleep and increases in night-time heart rate during the premenstrual week, with US women recording the lowest sleep scores.
Read More
The newly available oral orexin receptor 2 agonist offers clinicians the first opportunity to prescribe a targeted treatment for underlying orexin deficiency in narcolepsy type 1, with a US rollout expected soon.
Read More
The AASM Case Study of the Month for October is live! Years of severe daytime sleepiness and restless, interrupted sleep bring a 65-year-old man to the sleep clinic. His wife reports witnessed apneas and gasping, but an...
Read MoreAn AI-driven neurotechnology platform and a patient-led advocacy group have teamed up to reach people living with sleep disorders earlier in their diagnostic journeys and bring patient voices into clinical research.
Read More
This guide is a comprehensive comparison of the major home sleep tests on the market.
Read More